Selecta Biosciences, Inc.
Tolerogenic synthetic nanocarriers for generating CD8+ regulatory T cells

Last updated:

Abstract:

Disclosed are synthetic nanocarrier methods, and related compositions, comprising administering MHC Class I-restricted and/or MHC Class II-restricted epitopes of an antigen and immunosuppressants in order to generate tolerogenic immune responses against the antigen, such as the generation of antigen-specific CD8+ regulatory T cells.

Status:
Grant
Type:

Utility

Filling date:

27 Jul 2015

Issue date:

15 Oct 2019